The service enables patients from the region to make informed decisions about cancer care, with the aim of expanding their treatment options and improving clinical outcomes. 

 

Singapore medical start-up Oncoshot is partnering with digital healthcare provider MyDoc, to give cancer patients access to second opinion advice from leading oncologists. MyDoc will direct patients from within its network to Oncoshot’s specialist telemedicine platform, which offers remote medical advice from highly qualified oncologists as well as a clinical trial matching solution.

The service enables patients from the region to make informed decisions about cancer care, with the aim of expanding their treatment options and improving clinical outcomes. Cancer, the second leading cause of mortality worldwide, is rising in prevalence in Singapore. According to the Singapore Cancer Registry, one in four people in Singapore may develop cancer in their lifetime, and the number of people living with cancer will continue to increase.

However, with cancer care advancing at an unprecedented rate globally, cancer patients today can choose from a wellspring of treatment options with the potential to elevate their quality of life. Seeking a second opinion to complement their primary healthcare providers can provide them with reassurance on their diagnosis and expose them to a range of therapies.

“Through this partnership, more cancer patients will be able to tap into medical advice from leading private sector cancer care providers from Singapore and the region, and connect to clinical trials on cancer treatments through telemedicine services,” said Dr Huren Sivaraj, Oncoshot CEO and co-founder, who is a medical oncologist at the National Cancer Centre Singapore. “As the world continues to cope with the Covid-19 pandemic and travel remains a challenge, it is important for cancer patients to have easy and timely access to medical advice that allows for informed decision making. The Oncoshot platform gives patients and oncologists efficient access to all critical information relevant to each individual patient’s unique medical condition.”

Dr Vas Metupalle, chief information officer and co-founder, MyDoc, added: “For many patients, getting diagnosed with cancer is a nerve-wracking experience. It’s a complicated illness that requires long-term treatment and care, which is a difficult process for not just the patients, but also their families. Having the ability to conveniently get as much information as you can, from a platform like Oncoshot that provides specialists consultations and second opinions will be valuable. MyDoc will add local medical services in each of the regional countries to provide a supportive ecosystem for cancer patients. This is an important segment for us going forward.”

Besides second opinion advice, Oncoshot also connects patients with institutes around the world that are running clinical trials, through AI technology.

 

---